Clover Biopharmaceuticals, Ltd. (02197)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Ambrosino Donna Marie | 17-Jun-22 | NED | |||
| Chau Anita Hing Ling | 22-Dec-21 | CoSec | |||
| Clemens Ralf Leo | 17-Jun-22 | NED | |||
| Farrow Jeffrey | 26-Sep-21 | INED | |||
| Fung Po Ting | 19-Apr-21 | 22-Dec-21 | CoSec | ||
| Krex Brian | 19-Apr-21 | 31-Mar-23 | CoSec | ||
| Leggett Thomas | 26-Sep-21 | INED | |||
| Liang Joshua G | 25-Dec-20 | CEO | |||
| Liang Peng | 31-Oct-18 | Ch, Fdr | |||
| Liao Xiang | 26-Sep-21 | INED | |||
| Lyu Dong | 16-Mar-21 | 28-Oct-22 | NED | ||
| Wang Xiaodong | 16-Mar-21 | NED | |||
| Wang Xiaoyan | 31-Mar-23 | CoSec | |||
| Wu Xiaobin | 26-Sep-21 | INED | |||
| Xiao Ting | 16-Mar-21 | 22-Apr-22 | NED |